Welspun Living Ltd Q1 FY27 Earnings Analysis

Published 24 May 2026 | Textiles & Apparels | Market Cap: ₹12.4K Cr

Price

139

Market Cap

₹12.4K Cr

P/E Ratio

53.1

Revenue Rank

Rank 3

Margin Rank

Rank 1

Earnings Summary

- FY27 is expected to deliver double-digit growth in top-line revenue, signaling a strong recovery and scaling phase post-FY26 challenges. - ROCE expected to improve with growth around more than 15%, focusing on an asset-light model (Page 16).

📊 Revenue & Sales Performance

Rank 3

- FY27 is expected to deliver double-digit growth in top-line revenue, signaling a strong recovery and scaling phase post-FY26 challenges. - Domestic Indian market predicted to grow robustly at around 26% to 30%, driven by increased consumption and brand expansion. - Global B2B segment anticipates double-digit growth, supported by the U.S. and expansion into U.K., Europe, and other FTA-driven markets. - Sleep category (pillows) in the U.S. aims to nearly double revenue from $27.5 million to $60 million in FY27. - Flooring business targets 30% growth next year, primarily from soft flooring and expansion in regions like Australia, New Zealand, Middle East, U.K., and Europe. - Innovation-driven premiumization contributes around 22% to revenue growth, enhancing value-added product sales. - Medium-term aspiration to reach INR 15,000 crores revenue within 3 years, currently optimized capacity supports INR 11,500-12,000 crores. - Overall volume recovery is measured and supported by tariff easing and improving macroeconomic conditions globally.

📈 Profitability & Margins

Rank 1

- ROCE expected to improve with growth around more than 15%, focusing on an asset-light model (Page 16). - FY27 guided for double-digit revenue growth and EBITDA margins advancing into the teens, targeting teen EBITDA margin and growth (Pages 6, 12). - Q4 FY26 showed signs of recovery with a 7.7% sequential revenue growth and 10.8% EBITDA margin up 313 bps sequentially (Page 6). - Operating model stress-tested; focus on margin recovery led by operating leverage and mix improvement in FY27 (Page 3). - U.S. B2B pillows business expected to nearly double from $27.5 million to $60 million in FY27, contributing to growth (Page 13). - Domestic India market projected to grow 26-30% in FY27 adding to revenue growth (Page 14). - Flooring segment with potential 30% growth in FY27, especially soft flooring (Pages 5, 15). - Overall expecting improved utilization, operational discipline, and margin progression supporting profit growth (Pages 6, 8).

🏗️ Capital Expenditure Plans

Yes

- FY26 capex was INR472 crores, focused on productivity improvement, sustainability, and selective growth opportunities. - FY27 capex is expected to be INR400-500 crores, mainly towards modernization, automation, and debottlenecking operations. - USD 13 million approved for setting up a pillow manufacturing unit in Nevada, U.S., which partially commenced commercial production as of March 31, 2026. - Investments continue in innovation, sustainability, and nearshore manufacturing. - Focus on expanding manufacturing presence in the U.S. through Ohio and Nevada pillow facilities to support long-term growth in the sleep solutions category. - No concrete guidance on large M&A, but the company remains open to opportunities aligned with existing global brands and growth in various countries.

💰 Fundraising & Capital Structure

No information

- No explicit mention of new fundraising through debt or equity in the provided transcript. - The company reported a significant reduction in net debt to INR775 crores, down 52% from last year, reflecting strong cash flow management. - The company aims to be a net debt zero company by next year (FY27), barring any additional capex or special requirements. - FY27 capex is expected to be in the range of INR400-500 crores, focused on modernization, automation, and debottlenecking, likely funded through internal accruals. - Capital allocation is focused on disciplined use of cash, supported by a recent INR252 crore buyback from available cash. - No plans stated for equity fundraising; focus appears to be on debt reduction and internal funding for growth and capex.

📋 Order Book & Pipeline

No information

The transcript does not explicitly mention current or expected orderbook/pending orders details for Welspun Living Limited. However, some relevant points can be inferred regarding demand and growth outlook: - Utilization level was around 86% in FY26, with expectations to improve going forward, indicating healthy order flow. - Growth is expected to be double-digit globally in FY27 with India showing strong momentum at 26-30% growth. - U.S. business set to double from $27 million to $60 million in pillow segment next year. - FTAs in U.K. and Europe expected to create new growth opportunities. - Discussions with customers ongoing regarding tariffs and pricing amid raw material inflation, showing active order management. - No loss of customers despite tariff uncertainties and macro challenges. No precise value or quantitative figures on orderbook or pending orders are provided in the call transcript.

Key Metrics

Revenue

Rank 3

Margin

Rank 1

Capex

Yes

Fundraise

No information

Order Book

No information

Frequently Asked Questions

What were Welspun Living Ltd Q1 FY27 results?

- FY27 is expected to deliver double-digit growth in top-line revenue, signaling a strong recovery and scaling phase post-FY26 challenges. - ROCE expected to improve with growth around more than 15%, focusing on an asset-light model (Page 16).

What is Welspun Living Ltd share price analysis?

Welspun Living Ltd currently shows a below-average growth signal. The stock trades at a P/E of 53.1 with a market cap of ₹12,369. Investors should review the full earnings analysis for detailed insights.

Is Welspun Living Ltd planning capital expenditure?

- FY26 capex was INR472 crores, focused on productivity improvement, sustainability, and selective growth opportunities. - FY27 capex is expected to be INR400-500 crores, mainly towards modernization, automation, and debottlenecking operations. - USD 13 million approved for setting up a pillow manufacturing unit in Nevada, U.S., which partially commenced commercial production as of March 31, 2026. - Investments continue in innovation, sustainability, and nearshore manufacturing. - Focus on expanding manufacturing presence in the U.S.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.